Primeinvestor

Primeinvestor | Joined since 2017-11-22

Investing Experience -
Risk Profile -

Followers

0

Following

0

Blog Posts

0

Threads

1,454

Blogs

Threads

Portfolio

Follower

Following

Summary
Total comments
1,454
Past 30 days
0
Past 7 days
0
Today
0

User Comments
Stock

2018-05-22 23:31 | Report Abuse

You guys analyse it wrongly

Q1 - is about rm14m
Q3 will see new products and new plant to contribute to growth

Conservatively, penta should be able to do 60m profit this year, which means it is trading at 12x pe. Note there is a cash of 92cents. If minus out, penta is only at 8-9x pe

Compare to vitrox, penta should be able to double from current levels

Pentamaster international reported rm23m profit, which we think that rm95m for full year is possible with new plant coming in on q3, therefore, pil is only trading at 10x pe, but sitting at about rm180n net cash, therefore pil is only trading at 8x pe

Stock

2018-01-24 00:30 | Report Abuse

Looks like a turnaround company soon, Palette version 2

Stock

2018-01-24 00:28 | Report Abuse

The net cash is almost 31cents per share, which means you are buying an IT company (profit making) plus a new construction arm at 9 cents per share

If the company could secure 1-2 construction jobs, EPS could easily double or triple from here, this is a lost GOLD $

Stock

2018-01-24 00:26 | Report Abuse

Only traders will sell this company, 3 things to note for Ucrest

1) Revenue surged to a record high / profit after tax record high too
2) FY2018's revenue should close at RM40m (guided by Mr Eg) which means profit after tax of RM14m
3) RM14m is equivalent to FY2018 P/E of 13x right now
4) Private placement of 20% likely secured by identified investors - suspect could be Pathway, after raising cash, Ucrest will be able to execute more contracts going forward
5) The question is how much revenue will grow in FY2019? We would have to monitor contract flows.. From the looks of it, momentum should increase, lets see whether the Russian government will increase their budget for mobile healthcare this year vs last year.

If order book can double (my base case), profit after tax should close above RM30m in FY2019, then you are buying a high growth company at P/E of 6x. People who said Ucrest is a conjob could continue to sell, honestly I want to buy more after understanding what CIMB analyst has written on Palette, hopefully RM0.48 tomorrow